The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

12 Dec 2013 11:36

RNS Number : 3990V
Praetorian Resources Limited
12 December 2013
 



Praetorian Resources Limited

 

("Praetorian Resources" or the "Company")

 

Interim Results

 

Praetorian Resources (AIM: PRAE; PRSS) announces its results for the six months ended 30 September 2013.

 

An extract from the interim report appears below and the full version can be viewed on the Company's website at www.praetorianresources.com. Hard copies of the interims are available by request to

 

info@praetorianresources.com

 

 

For further information, please contact:-

 

Westhouse Securities Limited (Nominated Adviser)

Richard Baty +44 (0)20 7601 6100

 

 

Ocean Equities Limited (Broker)

Guy Wilkes +44 (0)20 7786 4370

 

 

Chairman's Statement

 

Dear Shareholder

 

Since our last statement to shareholders the junior resources market has failed to make up lost ground with the sector stubbornly refusing to respond to positive news. This continued negative environment has had a major impact on the net assets attributable to the Company's ordinary shares, which as at 30 September 2013 was £10,358,152 providing a Net Asset Value per Share of 21 pence.

 

In spite of an improving economic backcloth, junior resources companies continue to face extremely challenging conditions and are struggling to get any attention from the investment community. Volatile commodity prices and a prolonged funding drought are the critical drivers to poor sentiment in the sector. It is unlikely that the deterioration in market conditions can last for very much longer and we would expect a marginal improvement in share prices in the coming months. In order to position the Company to take any advantage of any upturn in the sector's fortunes, the management team continues to concentrate the portfolio on six key positions where they take a hands-on approach to building shareholder funds.

 

These six key positions equate to approximately 75% of the net asset value and we provide further details of these positions below.

 

Maya Gold and Silveris quoted on the TSX Venture Exchange and has a market capitalisation of approximately C$29m. The company is focused on developing its suite of mining assets in Morocco with its most advanced asset, the Zgounder silver mine, currently moving into commercial production. During 2013, Maya also acquired an 85% stake in the significant Boumadine polymetalic deposit winning the tender for this property against stiff opposition. With the short term prospect of material cash flow from Zgounder along with the further development of Boumadine, 2014 will be a pivotal year for Maya.

  

Polar Star Mining Corporation is a main board TSX listed Chilean copper / gold exploration and development company with a market capitalisation of approximately C$30m. The company's strategy is to develop its numerous Chilean assets via joint ventures and partnerships to allow it to benefit from any exploration success without having to overly dilute its equity to fund operations. Polar Star is hopeful for a positive 2014 with extensive drilling campaigns planned by BHP and other joint venture partners on the company's assets.

 

Galileo Resources plcis quoted on the AIM market and has a market capitalisation of approximately £10m. Earlier this year the company announced the results of the preliminary economic assessment (PEA) of its Glenover phosphate / rare earth asset in South Africa with an indicated IRR of 34.5% and NPV of USD 512m. We feel 2014 will be a year where Galileo explores ways for further optimising the results of the Glenover PEA while also looking at other opportunities to generate market interest until sentiment improves in the rare earth market.

 

A Cap Resources Limitedis quoted on the Australian Stock Exchange and has a market capitalisation of approximately A$12m. The company is attempting to become Botswana's leading energy company through the development of its uranium and coal assets. In June 2013, A-Cap announced a major upgrade to its JORC compliant uranium resource and is currently undertaking a pre-feasibility study with production targeted for 2016 at what will be Botswana's first uranium mine. Both its uranium and coal assets are substantial in size and the company is looking for sensible joint venture partners to assist with the development of these strategic assets.

 

Equatorial Palm Oil plcis quoted on the AIM market and has a market capitalisation of approximately £18m. The company is in the process of developing its three Liberian Palm Oil assets which total 169,000 hectares. The assets are held within a 50/50 Liberian joint venture company that the company co-owns with the Malaysian Palm Oil major Kuala Lumpur Kepong Bhd (KLK). Management hopes that 2014 will see the rapid development of the most advanced of its three assets, the 34,000 hectare Palm Bay Estate, located near the operating deep water port of Buchanan. Equatorial Palm Oil plc is currently subject to a mandatory takeover offer, from a wholly owned subsidiary of KLK, at 5 pence per ordinary share.

 

Besra Gold Incis quoted on both the Toronto Stock Exchange and Australian Stock Exchange and has a current market capitalisation of approximately C$13m. Besra is a pan-Asian gold company with two production assets in Vietnam and a significant development asset in Malaysia (currently 3.3m oz resource @ 1.44 g/t all within 100m from surface). Besra's management recently released the results of the definitive feasibility study for its flagship Bau asset with 2014 being the year where the company clarifies the development timetable for Bau as well as the required funding strategy.

 

Praetorian like many investment companies in the sector remains under-capitalised to take full advantage of the recovery prospects, thereby focusing the Board's efforts in raising additional finance. As you will have seen in our announcement in October 2013 an additional £1,500,000 was raised and the directors will continue to look for new capital in order to take the Company forward.

 

Your directors remain both optimistic and realistic about the future and we are expecting this notoriously cyclical sector to swing into the upside again in the not too distant future. In the meantime we are focused on working with our investee management teams to ensure the best possible returns for our Shareholders. This is taking considerably longer than we initially anticipated and we would like to thank all shareholders for their patience and continued support.

 

Robert King - Chairman

December 2013

 

 

 

 

 

 

 

 

Interim Condensed Consolidated Statement of Comprehensive Income

For the period 1 April 2013 to 30 September 2013

01/04/2013

*22/02/2012

to 30/09/2013

to 30/09/2012

Unaudited

Unaudited

 £

 £

Income

Net capital loss on financial assets at fair value through profit or loss

(5,135,749)

(1,624,691)

Net investment gains and losses

(5,135,749)

(1,624,691)

Expenses

Directors' fees and expenses

(49,139)

(25,000)

Administration fees

(37,144)

(14,516)

Support services administration fees

(82,791)

(45,246)

Audit fees

(10,417)

(16,000)

Custodian fees

(4,636)

(2,829)

Broker fees

(12,747)

(6,963)

Consultancy fees

(62,000)

(33,500)

Registrar fees

(6,124)

(1,375)

Other expenses

(49,243)

(26,464)

Total expenses

(314,241)

(171,893)

Operating loss

(5,449,990)

(1,796,584)

Finance income

565

3,124

Finance costs

(9,969)

(78,519)

Loss for the financial period

(5,459,394)

(1,871,979)

Other comprehensive income for the period

-

-

Total comprehensive expense for the period

(5,459,394)

(1,871,979)

Basic and diluted deficit per share (pence)

(11.10)

(4.12)

(Based on weighted average number of Ordinary shares of 49,176,334 (2012 : 45,407,173)

* - The Company was incorporated on 22 February 2012 and dealings on AIM commenced on 9 July 2012 hence the trading activity of the Company was for the period 9 July to 30 September 2012.

All activities derive from continuing operations.

All income is attributable to the holders of the Ordinary Shares of the Company.

 

 

Interim Condensed Consolidated Statement of Financial Position

As at 30 September 2013

30/09/2013

31/03/2013

Unaudited

Audited

 £

 £

ASSETS

Non-Current Assets

Investments at fair value through profit or loss

10,364,861

15,325,843

Total non-current assets

10,364,861

15,325,843

Current Assets

Trade and other receivables

14,511

5,176

Cash and cash equivalents

89,228

826,052

Total current assets

103,739

831,228

Total Assets

10,468,600

16,157,071

EQUITY AND LIABILITIES

Equity

Shares issued

24,677,936

24,677,901

Treasury shares

(310,655)

-

Retained earnings

(14,009,129)

(8,549,735)

Total Equity

10,358,152

16,128,166

Liabilities

Current Liabilities

Trade and other payables

110,448

28,905

Total current liabilities

110,448

28,905

Total equity and liabilities

10,468,600

16,157,071

Net asset value per Ordinary Share (excluding shares held in Treasury)

0.21

0.32

 

Interim Condensed Consolidated Statement of Changes in Equity

For the period 1 April 2013 to 30 September 2013

Share Capital

Treasury Shares

Retained Earnings

Total Equity

Unaudited

Unaudited

Unaudited

Unaudited

 £

 £

 £

 £

At 1 April 2013

24,677,901

-

(8,549,735)

16,128,166

Total comprehensive expense for the period

-

-

(5,459,394)

(5,459,394)

24,677,901

-

(14,009,129)

10,668,772

Transactions with owners

Shares issued

35

-

-

35

Share buybacks

-

(310,000)

-

(310,000)

Share transaction costs

-

(655)

-

(655)

Total transactions with owners

35

(310,655)

-

(310,620)

At 30 September 2013

24,677,936

(310,655)

(14,009,129)

10,358,152

As at 22 February 2012

-

-

-

Total comprehensive expense for the period

-

(1,871,979)

(1,871,979)

Transactions with owners

Shares issued

25,231,101

-

25,231,101

Share issue costs

(549,399)

-

(549,399)

Total transactions with owners

24,681,702

-

24,681,702

At 30 September 2012

24,681,702

(1,871,979)

22,809,723

 

 

  

 

Interim Condensed Consolidated Statement of Cash Flows

For the period 1 April 2013 to 30 September 2013

01/04/2013

22/02/2012

to 30/09/2013

to 30/09/2012

 £

 £

Cash flows from operating activities

Purchase of investments

(739,847)

(6,218,012)

Proceeds from sale of investments

565,080

1,542,614

Interest received

565

3,124

Operating expenses paid

(252,002)

(219,293)

Net cash outflow from operating activities

(426,204)

(4,891,567)

Cash flows from financing activities

Proceeds from issue of shares

35

9,322,510

Share buybacks

(310,000)

-

Share transaction costs

(655)

(531,315)

Net cash (outflow) / inflow from financing activities

(310,620)

8,791,195

Net change in cash and cash equivalents

(736,824)

3,899,628

Cash and cash equivalents at beginning of period

826,052

-

Cash and cash equivalents at end of period

89,228

3,899,628

 

 

1. FINANCIAL INFORMATION

 

The financial information set out above does not constitute the Company's Interim accounts for the period ended 30 September 2013, but is derived from those accounts.

 

The unaudited condensed consolidated financial statements of the Group ("Interim Statements") have been prepared in accordance with International Accounting Standard ("IAS") 34: Interim Financial Reporting. The Interim Statements do not include all the information and disclosures required in annual financial statements, and should be read in conjunction with the Company's Annual Report and Consolidated Financial Statements for the period ended 31 March 2013 ("2013 Annual Report"), which were prepared in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union and applicable Guernsey law and are available at

 

www.praetorianresources.com.

 

  

2. REVIEW OF CENTRAL COSTS

 

During the six month period to 30 September 2013 the Company has undertaken a careful review of its central costs. Mr Andrew Ferguson and Mr Malcolm Burne have voluntarily resigned from the Board for no compensation with effect from 27 June 2013. Mr Burne and Mr Cannon-Brookes have each agreed, with effect from 1 April 2013 and until further notice, to defer any future fees or personal entitlements due to them in order to minimise cash payments out of the Company. 

 

The Directors fees of Richard Lockwood and Mark Hohnen have similarly been deferred until further notice.

 

Robert King has waived his entitlement to his Directors fee for Praetorian Resources (GP) Limited with effect from 1 April 2013.

 

These deferred fees and entitlements will continue to be accrued and therefore reflected within the Company's NAV but no cash payments have been, or will be, made until further notice.

 

 

 

3. INVESTMENTS AT FAIR VALUE THROUGH PROFIT OR LOSS

 

For the period ended 30 September 2013 - Unaudited

Level 1

Level 2

Level 3

Total

 £

 £

 £

 £

Opening Cost

22,132,351

-

1,314,499

23,446,850

Additions at cost - cash

739,847

-

-

739,847

Disposals proceeds

(565,080)

-

-

(565,080)

Net realised loss on disposal of investments

(1,151,754)

-

-

(1,151,754)

Closing portfolio cost

21,155,364

-

1,314,499

22,469,863

Net unrealised (loss) / gain on investments

(11,171,182)

35,600

(969,420)

(12,105,002)

Closing valuation

9,984,182

35,600

345,079

10,364,861

Net unrealised (loss) / gain on investments

(3,962,402)

35,600

(57,193)

(3,983,995)

Net realised loss on disposal of investments

(1,151,754)

-

-

(1,151,754)

Net capital (loss) / gain on fair value of financial assets designated at fair value through profit or loss

(5,114,156)

35,600

(57,193)

(5,135,749)

Investment income

-

-

-

-

Total (losses)/gains on Financial Assets at fair value through profit or loss

(5,114,156)

35,600

(57,193)

(5,135,749)

For the period ended 31 March 2013 - Audited

Opening Cost

-

-

-

-

Additions at cost - in specie

14,713,092

-

1,314,499

16,027,591

Additions at cost - cash

11,160,840

-

-

11,160,840

Disposals proceeds

(3,873,013)

-

-

(3,873,013)

Net realised gain on disposal of investments

131,432

-

-

131,432

Closing portfolio cost

22,132,351

-

1,314,499

23,446,850

Net unrealised loss on investments

(7,208,780)

-

(912,227)

(8,121,007)

Closing valuation

14,923,571

-

402,272

15,325,843

Net unrealised loss on investments

(7,208,780)

-

(912,227)

(8,121,007)

Net realised gain on disposal of investments

131,432

-

-

131,432

Net capital loss on fair value of financial assets designated at fair value through profit or loss

(7,077,348)

-

(912,227)

(7,989,575)

Investment income

25,735

-

-

25,735

Total losses on Financial Assets at fair value through profit or loss

(7,051,613)

-

(912,227)

(7,963,840)

The current strategy of the Group, as discussed in the 2013 Annual Report, is to concentrate the portfolio on six key positions on which the Group can support and assist in management. As at the period end these key positions constitute 73% (31 March 2013: 68%) of the NAV of the Group.

 

4. BASIC AND DILLUTED DEFICIT PER ORDINARY SHARE

£

Loss for the period

(5,459,394)

Weighted average number of ordinary shares in issue

49,176,334

EPS (pence)

(0.11)

The earnings per share is based on the loss for the period and on the weighted average number of ordinary shares in issue for the period.

The Group's subscription shares could potentially dilute the earnings per share in the future.

 

 

5. NET ASSET VALUE PER ORDINARY SHARE

£

Net assets

10,358,152

Ordinary shares in issue

49,093,951

Net asset value per share (pence)

0.21

On 16 April 2013 the Company announced an on market share buy back of 1,000,000 ordinary shares at a price of 31 pence each. These buy back shares will be held in the Company as Treasury shares, and while held as such carry no voting rights. The Directors only intend to purchase Ordinary Shares where they believe such purchases will result in an increase in the NAV per Ordinary Share and will assist in narrowing any discount to the NAV per Ordinary Share at which the Ordinary Shares may be trading. When Ordinary Shares trade at a substantial discount to the NAV per Ordinary Share and do not coincide with trading volumes in the market, the Directors may feel that it is appropriate to make such purchases.

 

 

6. EVENTS AFTER THE FINANCIAL REPORTING DATE

The Company announced on 30 October 2013 that it had entered into a funding agreement (the 'Agreement') with Damille Investments II Limited ('Damille') to raise £1,500,000. The Agreement has been entered into through a newly incorporated wholly owned subsidiary of the Company, Praetorian ZDP Limited ('Praetorian ZDP'). Praetorian ZDP is a special purpose vehicle incorporated for the sole purpose of entering into the Agreement.

Under the Agreement, Praetorian ZDP issued 1,500,000 unlisted, zero dividend preference shares (the 'Shares') to Damille for a consideration of £1,500,000 (the 'Subscription Price'). The Shares carry an annually compounded coupon of 11% and have a maximum three year term from the date of signing the Agreement. The Company has agreed to pay Damille a facility fee of 2% of the Subscription Price which is due within 14 days of signing the Agreement. Praetorian ZDP has the right to redeem the Shares prior to the end of the three year term by giving Damille no less than 30 days written notice; by repaying the accrued capital entitlement per ZDP Share ("Capital") plus the accrued compounded coupon to that redemption date and by paying a redemption fee equating to 5% of the sum of the Capital and accrued compounded coupon at the date of redemption .

The Company has undertaken to maintain a net asset value coverage of 4.5 times the Subscription Price plus the compounded coupon due for the full three year term (the 'Cover Test'). If the Cover Test is not satisfied as at the date of two consecutive quarterly net asset value publications, the Company will place into escrow 50% of any asset realisations until such time that the Cover Test is once again satisfied, at which point all escrowed funds will be returned to the Company.

 

As part of the Agreement, the Company issued 7,263,922 unlisted warrants to Damille with an exercise price of £0.2065 per warrant (to subscribe for ordinary shares in the Company on a 1:1 basis). The warrants are exercisable immediately and for a period of three years from the date of the Agreement. In addition, Damille has the right to appoint one director to the board of both the Company and Praetorian ZDP so long as they continue to hold 75% of the Shares (excluding any ZDP Shares redeemed by the Company).

The newly invested funds will be loaned by Praetorian ZDP to the Company for working capital and investment purposes. The Company board continues to maintain its prudent central cost base and the Company directors and board advisors will continue to defer or maintain their substantially reduced fees until further notice.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FLLFFXLFXFBB
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.